您的位置: 首页 > 农业专利 > 详情页

TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM THE EYE
专利权人:
Buck Institute for Research on Aging;Mayo Foundation for Medical Education and Research;Unity Biotechnology, Inc.
发明人:
Remi-Martin Laberge,Judith Campisi,Marco Demaria,Nathaniel David,Alain Philippe Vasserot,James L. Kirkland,Tamar Tchkonia,Yi Zhu
申请号:
US15827539
公开号:
US20180117038A1
申请日:
2017.11.30
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充